Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer

BACKGROUND: Clinical practice guidelines provide separate recommendations for different diseases that may be prevented or treated by the same intervention. Also, they commonly provide recommendations for entire populations but not for individuals. To address these two limitations, our aim was to con...

Descripción completa

Detalles Bibliográficos
Autores principales: Puhan, Milo A., Yu, Tsung, Stegeman, Inge, Varadhan, Ravi, Singh, Sonal, Boyd, Cynthia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589917/
https://www.ncbi.nlm.nih.gov/pubmed/26423305
http://dx.doi.org/10.1186/s12916-015-0493-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589917/
https://www.ncbi.nlm.nih.gov/pubmed/26423305
http://dx.doi.org/10.1186/s12916-015-0493-2

Ejemplares similares